Media Library
Stay up-to-date on our latest news and find resources for journalists.
Stay up-to-date on our latest news and find resources for journalists.
Sep 6, 2026
Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults
Mar 25, 2026
Clover Announces Additional Positive U.S. Phase I Clinical Data for RSV Re-Vaccination in Older Adults
Jan 11, 2026
Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
Oct 20, 2025
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
Picture: Employees prepare Clover's COVID-19 vaccine for shipment
Picture: Clover's COVID-19 vaccine
Picture: Changxing facility employees prepare Clover's COVID-19 vaccine for shipment
Picture: Equipment at Clover's Changxing facility
Picture: Equipment at Clover's Changxing facility
Picture: Laboratory at Clover's Changxing facility
Picture: Clover's Changxing manufacturing facility
Video: Clover's Changxing manufacturing facility
